Nearly 7 million people in the United States are living with heart failure, and that number is expected to grow in the years ...

A diabetes drug called dapagliflozin may help prevent heart failure in people with genetic variants linked to cardiomyopathy, ...

Nearly 7 million people in the United States are living with heart failure, and that number is expected to grow in the years ...

Prevention—be it primary, secondary, or even tertiary—should be the primary focus in heart failure (HF) care, according to a new scientific statement published jointly by the Heart Failure Society of ...

Researchers believe the findings could reshape how doctors approach prediabetes treatment. Traditionally, cardiovascular ...

A heart attack is far from an isolated, acute event. The consequences of an attack can cause serious and lasting damage, ...

After developing heart failure, 52.6 percent of patients die within five years, and the most significant cause of heart failure is a heart attack, which affects more than 800,000 Americans each year.

When the heart struggles to pump efficiently, a cascade of events unfolds. Fluid accumulates in the lungs and extremities. Breathing becomes labored. Simple activities like climbing stairs or carrying ...

Liz covers cardiovascular and metabolic disease, asking why we’re not doing better or even losing ground against the world’s leading killer. Send tips on Signal at LizC.22. Just over a year ago the ...

Dapagliflozin cuts heart failure hospitalisations by 80% in high-risk genetic carriers ...

For millions of people with heart failure, the latest treatment options — including advanced surgical procedures and innovative devices to assist a failing heart — can be game-changing, especially ...

Many women worry about breast cancer and other well-known health risks, but cardiologists warn that heart disease remains the ...